Acuitas: (noun) insight, perception, sharpness.

TECHNOLOGY

PARTNERING

FEATURED NEWS

NEWS: DEVELOPMENT OF A NUCLEOSIDE-MODIFIED mRNA VACCINE AGAINST CLADE 2.3.4.4b H5 HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS (MAY 2024)

Congratulations to Steven Fan, co-author of a recent study featured in Nature Communications. He collaborated with scientists from Scott Hensley’s group at the University of Pennsylvania demonstrating that a monovalent mRNA-LNP vaccine expressing 2.3.4.4b H5 is immunogenic and protective in pre-clinical animal models.

Click to read more info.

NEWS: ASGCT ANNUAL MEETING NEWS RELEASE (MAY 2024)

As the global leader in lipid nanoparticle delivery systems, Acuitas scientists, Dr. Ying Tam and Sean Semple, delivered poster presentations at the American Society of Gene + Cell Therapy Annual Meeting. Click to read the poster presentations.

NEWS: MRNA-LNP VACCINE-INDUCED CD8+ T-CELLS PROTECT MICE FROM LETHAL SARS-COV-2 INFECTION IN THE ABSENCE OF SPECIFIC ANTIBODIES (APR 2024)

Congratulations to Ying Tam and Molly Sung, co-authors of a recent study featured in Molecular Therapy. They collaborated with scientists from Thomas Jefferson University using mouse-adapted SARS-CoV-2 virus (MA30) in C57BL/6 mice, showing that CD8+ T cells are unnecessary for the intrinsic resistance of female or the susceptibility of male mice to lethal SARS-CoV-2 infection. Click to read more info.